Ulcerative Colitis

LAS VEGAS – Matching-adjusted indirect comparisons found a positive benefit-risk profile for ozanimod vs. adalimumab and a comparable profile for ozanimod vs. vedolizumab.

LAS VEGAS – Physicians should remember there are many points to consider when selecting the right treatment for patients with ulcerative colitis, according to a presenter at the ACG Annual Scientific Meeting.

Patients with pediatric onset inflammatory bowel disease may have a higher risk for cancer and death, according to a presentation at UEG Week Virtual 2021.

In a video exclusive, Subrata Ghosh, MD, of the University College Cork, reported older patients with inflammatory bowel disease treated with Stelara did not experience increased rates of serious adverse events compared with placebo.

Among pediatric patients with Crohn’s disease and ulcerative colitis, the risk for incidence of intestinal resection and colectomy after 5 years of diagnosis decreased over a 24-year period, according to a presenter at UEG Week.

Remo Panaccione, MD, of the University of Calgary, reported Rinvoq safely and effectively maintained moderate-to-severe ulcerative colitis.

Patients with ulcerative colitis following a novel diet achieved higher clinical remission and mucosal healing compared with patients who received a single donor fecal transplantation, with or without diet, according to a study.

Zeposia compared with placebo was more effective as an induction and maintenance therapy in patients with moderately to severely active ulcerative colitis, according to a study published in The New England Journal of Medicine.

Loss of response to anti-tumor necrosis factor-alpha among patients with inflammatory bowel disease decreased in incidence following two years of treatment, according to research published in Alimentary Pharmacology & Therapeutics.

The American Gastroenterological Association published a conceptual model and clinical practice update for the prevention, detection and management of colorectal dysplasia in patients with inflammatory bowel disease.